Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New COX-2 inhibitors in early development at American Home

Aug. 18, 1998

Chiral aspects of the pharmacokinetics of flobufen: important implications for therapeutic use

Aug. 14, 1998

NSAID from Sigma-Tau is devoid of GI side effects

Aug. 13, 1998

Pfizer investigates COX-2 inhibitors as potential antiinflammatory agents

Aug. 13, 1998

Hoechst discovers modulators of leukocyte adhesion and migration

Aug. 12, 1998

COX-2 inhibitors selective for the human enzyme discovered at Nycomed Innovations

Aug. 11, 1998

Bayer discovers new MMP inhibitors for arthritic diseases

Aug. 11, 1998

FDA committee recommends approval of Arava for the treatment of rheumatoid arthritis

Aug. 11, 1998

Hoechst describes new compounds for rheumatoid arthritis and allergy

Aug. 11, 1998

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...